| Title | Author(s) | Year | View Count |
 | Mechanism of entecavir resistance of hepatitis B virus with viral breakthrough as determined by long-term clinical assessment and molecular docking simulation | Mukaide, M; Tanaka, Y; ShinI, T; Yuen, MF; Kurbanov, F; Yokosuka, O; Sata, M; Karino, Y; Yamada, G; Sakaguchi, K; Orito, E; Inoue, M; Baqai, S; Lai, CL; Mizokami, M | 2010 | 161 |
 | Three-year assessment of entecavir resistance in chronic hepatitis B patients and the mechanism of viral breakthrough by the resistance substitutions | Tanaka, Y; Mukaide, M; Yuen, RMF; Shin, IT; Orito, E; Kurbanov, F; Fukai, K; Yokosuka, O; Sata, M; Ide, T; Karino, Y; Yamada, G; Sakaguchi, K; Inoue, M; Gish, RG; Lai, CL; Mizokami, M | 2008 | 177 |
| Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma | Tanaka, Y; Mukaide, M; Orito, E; Yuen, MF; Ito, K; Kurbanov, F; Sugauchi, F; Asahina, Y; Izumi, N; Kato, M; Lai, CL; Ueda, R; Mizokami, M | 2006 | 100 |
| A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C | Orito, E; Fujiwara, K; Tanaka, Y; Yuen, MF; Lai, CL; Kato, T; Sugauchi, F; Kusakabe, A; Sata, M; Okanoue, T; Niitsuma, H; Sakugawa, H; Hasegawa, I; Mizokami, M | 2006 | 105 |
| Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality | Tanaka, Y; Kurbanov, F; Mano, S; Orito, E; Vargas, V; Esteban, JI; Yuen, M; Lai, C; Kramvis, A; Kew, MC; Smuts, HE; Netesov, SV; Alter, HJ; Mizokami, M | 2006 | 112 |
| T1653 mutation in the box α increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C Infection | Ito, K; Tanaka, Y; Orito, E; Sugiyama, M; Fujiwara, K; Sugauchi, F; Kato, T; Tokita, H; Izumi, N; Kato, M; Yuen, MF; Lai, CL; Gish, RG; Ueda, R; Mizokemi, M | 2006 | 47 |
| Two subtypes (subgenotypes) of hepatitis B virus genotype C: A novel subtyping assay based on restriction fragment length polymorphism | Tanaka, Y; Orito, E; Yuen, MF; Mukaide, M; Sugauchi, F; Ito, K; Ozasa, A; Sakamoto, T; Kurbanov, F; Lai, CL; Mizokami, M | 2005 | 160 |
| T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection | Ito, K; Tanaka, Y; Sugiyama, M; Fujiwara, K; Sugauchi, F; Orito, E; Asahina, Y; Tokita, H; Yuen, RMF; Lai, CL; Acharya, SA; Gish, R; Mizokami, M | 2005 | 109 |
| Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C | Sugauchi, F; Orito, E; Ichida, T; Kato, H; Sakugawa, H; Kakumu, S; Ishida, T; Chutaputti, A; Lai, CL; Gish, RG; Ueda, R; Miyakawa, Y; Mizokami, M | 2003 | 105 |
 | Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene | Sugauchi, F; Orito, E; Ichida, T; Kato, H; Sakugawa, H; Kakumu, S; Ishida, T; Chutaputti, A; Lai, CL; Ueda, R; Miyakawa, Y; Mizokami, M | 2002 | 225 |
|
